Homocysteine

Bradley A Maron1, Joseph Loscalzo

  • 1Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.

Insights

High homocysteine levels are linked to vascular diseases like heart and stroke. Accurate lab testing is crucial for predicting risk, but universal guidelines for homocysteine measurement are still needed.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Clinical Chemistry

Background:

  • Elevated homocysteine levels are recognized as a significant risk factor for various vascular diseases.
  • Hyperhomocysteinemia is specifically implicated in coronary artery disease, cerebrovascular disease, and peripheral arterial disease.
  • Accurate detection and quantification of homocysteine are essential for effective cardiovascular risk prediction.

Purpose of the Study:

  • To review the evolution of laboratory strategies for homocysteine detection and quantification.
  • To highlight the need for improved accuracy in risk prediction for vascular diseases.
  • To address the lack of universal guidelines for circulating homocysteine determination.

Main Methods:

  • Review of laboratory-based strategies for homocysteine measurement.
  • Analysis of technological advancements in homocysteine quantification over the past two decades.
  • Assessment of the current landscape of homocysteine determination guidelines.

Main Results:

  • Homocysteine is a validated risk factor for multiple vascular pathologies.
  • Laboratory detection and quantification methods have advanced significantly in precision.
  • Despite technological progress, universal guidelines for homocysteine measurement are absent.

Conclusions:

  • Accurate measurement of homocysteine is vital for vascular disease risk assessment.
  • Continued development in analytical techniques enhances precision but does not resolve guideline discrepancies.
  • The absence of universal guidelines poses challenges for consistent clinical application and risk stratification.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...
Amino Acid Catabolism01:18

Amino Acid Catabolism

Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...